Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guérin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may …read more Source:: Science
Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guérin to reverse advanced type 1 diabetes demonstrate a potential new mechanism by which the BCG vaccine may …read more Source:: Science